SAN JOSE, Calif., Aug. 29, 2011 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), has announced the latest round of winners of the BD Biosciences Research Grant Program.
"BD Biosciences continues to support promising young U.S. and European scientists at critical junctures of their careers," said Robert Balderas, Vice President of Biological Sciences, BD Biosciences. "No biomedical discovery has shown as much promise, so early in its development, as stem cell research. We are pleased, by funding these researchers, to support efforts to treat and cure serious illnesses."
An independent panel of distinguished scientists selected the winners. Each grant recipient will receive a $10,000 grant of research reagents to help carry out their research.
The winners of the BD Biosciences Research Grant Program for the summer 2011 cycle are:
- Michael Choi, M.D., Assistant Professor of Medicine at Harvard Medical School, is investigating the conversion of non-liver cells into functional hepatocytes through a combination of transcription factors and microRNAs. Specifically, he will identify transcription factors and microRNAs that help convert or differentiate fibroblasts, embryonic stem cells or endodermal (early liver precursor) cells into hepatic progenitor cells. The long-term goal is a ready source of cells to repair livers damaged from injury or disease.
Page: 1 2 3 4 Related biology technology :1
- Piero Dalerba, M.D., Instructor in Medicine at Stanford University, applies stem cell biology to the study and modeling of human cancer. Using a novel analytical method called single-cell gene expression analysis by polymerase chain reaction, he hopes to deconvolute the cell composition of the human colon epithelium and characterize its different cell populations, with an emphasis on stem cells. These cells are difficult to isolate and investigate because t
. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 20082
. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences3
. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update4
. Milestone Biosciences, LLC Further Strengthens Executive Management Team5
. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update6
. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America7
. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies8
. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference9
. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo10
. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium11
. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)